<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy

<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy

Gallium-68 (<sup>68</sup>Ga) radiopharmaceuticals are increasingly used in nuclear medicine due to their rapid production capabilities and exceptional specificity in molecular imaging applications. Several of these tracers have demonstrated remarkable clinical efficacy across various onc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marzia Rizzello, Anna Pacelli, Maria Domenica De Bari, Annalisa Cutrignelli, Rosa Maria Iacobazzi, Antonio Lopalco, Nunzio Denora
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Pharmaceutics
Subjects:	gallium-68 PSMA DOTATOC FAPI extemporaneous preparations radiopharmaceuticals
Online Access:	https://www.mdpi.com/1999-4923/17/7/802
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PET/CT WITH 68GA-FAPI46 FOR THE DETECTION OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH DIFFERENT TYPES OF CANCER. INITIAL EXPERIENCE
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2025-05-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

Optimizing Standardization Systems and Standardizing Clinical Practice: Interpretation of Quality Standards for Medical 68Ge/68Ga Generators and 68Ga Radiopharmaceuticals and Quality Standards for Medical 177Lu and Its Radiopharmaceuticals
by: LAI Yuxin, et al.
Published: (2025-07-01)

Towards a General Method for Using Cyclotron-Produced Ga68 to Manufacture Clinical and Research Ga68 Tracers
by: Ivan E. Wang, et al.
Published: (2024-11-01)

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024-10-01)

Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
by: O. E. Klementyeva, et al.
Published: (2020-08-01)

Cutting the Gordian Knot: Rare Presentation of Nodular Fasciitis as Supraclavicular Swelling with Muscular Involvement in <sup>68</sup>Ga-FAPI-PET/CT
by: Lukas A. Brust, et al.
Published: (2024-10-01)

Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease
by: Matthieu Bailly, et al.
Published: (2025-03-01)

Specific reaction conditions for efficient automated 68Ga-radiolabeling of the FAP-2286 pseudopeptide on a GAIA® synthesizer
by: Maissa Ammour, et al.
Published: (2025-07-01)

Application of 68Ga‐ and 177Lu‐Labeled FAP Inhibitor in Evaluation and Treatment of Cardiac Fibrosis After Myocardial Infarction
by: Yiheng Zhao, et al.
Published: (2025-06-01)

Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform
by: Sebastian Martin, et al.
Published: (2024-12-01)

An Innovative Approach with [<sup>68</sup>Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings
by: Gozde Mutevelizade, et al.
Published: (2025-07-01)

Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled [diF-Pro<sup>14</sup>]Bombesin(6−14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
by: Lei Wang, et al.
Published: (2025-02-01)

Molecular Imaging of Fibroblast Activation Protein in Response to Cardiac Injury Using [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Victoria Weissenböck, et al.
Published: (2025-04-01)

αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin
by: Jana Rehm, et al.
Published: (2024-11-01)

EVALUATION OF 68Ge/68Ga GENERATOR PRE-ELUTION EFFICIENCY ON METALLIC IMPURITIES IN THE COMPOSITION OF 68GaPSMA-11 RADIOPHARMACEUTICAL IN NUCLEAR MEDICINE PET CHEMISTRY
by: Ayşe Uğur, et al.
Published: (2021-09-01)

Stability Assessment of Furosemide Oral Suspension in Hospital Extemporaneous Preparations
by: Fai Alkathiri, et al.
Published: (2025-06-01)

EXTEMPORANEOUS MANUFACTURING OF INTRAVENOUS ADMIXTURES IN HOSPITAL PHARMACIES OF RUSSIAN FEDERATION
by: G. N. Kovalskaya, et al.
Published: (2017-09-01)

Regulation in the sphere of circulation of extemporaneously compounded medicines under modern conditions of Russia
by: V. V. Ryazhenov, et al.
Published: (2025-06-01)

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents
by: Ute Hennrich, et al.
Published: (2025-06-01)

Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE
by: Stephan Raad, et al.
Published: (2025-07-01)

Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617
by: A. A. Larenkov, et al.
Published: (2022-12-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

Preliminary clinical study of p-iodo benzoyl moiety-modified PSMA inhibitors and prospective comparison with 68Ga-PSMA-11
by: Jianpeng Cao, et al.
Published: (2025-06-01)

USAGE OF FINISHED DOSAGE FORMS IN THE MANUFACTURE OF EXTEMPORANEOUS POWDERS
by: A. V. Belyatskaya, et al.
Published: (2019-01-01)

Comparison of 68Ga-FAPI-04 PET/CT with CECT in the evaluation of peritoneal metastases from gastrointestinal cancers and impact on clinical decision-making
by: Yushan Zhou, et al.
Published: (2025-07-01)

Unexpected discovery of hepatic cancer via 68Ga-PSMA PET/CT in the staging of prostate cancer
by: Radu Alexa, et al.
Published: (2025-06-01)

Impact of 68Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer
by: Shunyu Zhang, et al.
Published: (2025-01-01)

Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
by: K. Pełka, et al.
Published: (2025-01-01)

A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor
by: Asahi Sato, et al.
Published: (2017-07-01)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board
by: S. Spreckelmeyer, et al.
Published: (2025-03-01)

A case of well-differentiated hepatocellular carcinoma identified on gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography
by: Hian Huang, et al.
Published: (2018-04-01)

The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study
by: Atefeh Zamanian, et al.
Published: (2025-07-01)

COMPETITION RESPONSE OF PSMA-I&T RADIOLABELED WITH LUTETIUM-177 TO LNCAP, PC-3 AND RWPE-1 CELLS
by: Luiza M Balieiro, et al.
Published: (2025-05-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

Current and Future Pharmacopoeial Requirements for the Quality of Extemporaneous Medicinal Products: A Review of Regulatory Standards
by: L. I. Shishova, et al.
Published: (2024-09-01)

Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01)

New role of extemporaneous manufacturing in regulating drug products access onto the market
by: A. V. Alekhin, et al.
Published: (2023-08-01)

THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER
by: Duygu Has Şimşek, et al.
Published: (2021-01-01)

68Ga-FAPI PET/CT for diagnostic accuracy and therapeutic response assessment in bleomycin-induced pulmonary fibrosis: an integrated preclinical study
by: Rui Sun, et al.
Published: (2025-06-01)